| | | WITH SHAH GILANI | | Silicon Valley Insider Who Called Crypto and Pot Boom Issues NEW Prediction for 2019
Move on 5G as fast as you can! A NEW, $12 trillion market could be about to burst wide open, igniting a crazy and relentless cash stampede! And you could pocket 10-fold gains from just one lucrative play - if you move NOW! Urgent details here.
February 26, 2019
Elon Musk's Twitter Ego Could Destroy Tesla by Shah Gilani
Dear Wall Street Insights & Indictments Reader,
Elon Musk, the founder, chief executive officer, and former chairman of Tesla Inc. (NasdaqGS:TSLA), is in trouble with the Securities and Exchange Commission (SEC)...
Again.
This time, he's in hot water for doing what he agreed not to do in the September 2018 settlement he made with the SEC over his infamous August 2018 "Am considering taking Tesla private at $420. Funding secured" tweet.
What happened this time and what led up to it isn't just a problem for Musk, it's a problem for Tesla.
And it's all coming to a boil...
Here's what else I'm following...
Retirees: This is how you can prosper even during the steepest economic decline
Did government incompetence cheat you out of $23,441?
You won't believe what this Colorado banker found on his property...
People pay thousands for a shot at these results (it could be yours risk-free)
How I Went from Driving a Forklift to Driving a Tesla Whether you're a beginner or a trading pro, my America's #1 Pattern Trader Cash Course can help you reach your goals faster than ever. I'll teach you the basics, A-Z, from how to set up your account to how to place your first trade. And once you're up to speed, I'll teach you secrets that no one else can - the same secrets that allowed me to go from a forklift driver at Home Depot to a millionaire many times over. No matter where you're at, this Cash Course can help you reach your goals faster than ever. To take your first step in making your dream life a reality, click here now.
The Biotech Play Worth $83 Billion The biotech sector has been thriving thanks to [TVD1] mergers and acquisitions. Tiny firms are skyrocketing - one in particular soared 66% in a single trading session on the news of an $8 billion buyout from a well-known pharma giant. Three more deals went down shortly after - totaling $83 billion in buyouts. If you want to grab deals like this before it's too late, click here to find out the next stock poised to jump and get FREE Strategic Tech Investor reports delivered straight to your inbox.
Share This Article: | You are receiving this email at its028@gmail.com as a part of your free subscription to Wall Street Insights & Indictments.
Remove your email from this list: Unsubscribe
Manage Your Email Preferences
To cancel by mail or for any other subscription issues, write us at: Wall Street Insights & Indictments | Attn: Member Services | 1125 N Charles Street | Baltimore, MD 21201 North America: 888.384.8339; International: 443.353.4519; Fax: 410.622.3050 Contact Customer Service Website: https://wallstreetinsightsandindictments.com/
© 2019 Wall Street Insights & Indictments All Rights Reserved.
Copyright - 2019 Money Map Press, LLC. The Money Map Press is a publishing company that does not act as a personal investment advisor for any specific individual. Nor do we advocate the purchase or sale of any security or investment for any specific individual. The proprietary recommendations and analysis we present to readers is for the exclusive use of subscribers. Readers should be aware that although our track record is highly rated, and has been legally reviewed for presentation in this invitation, investment markets have inherent risks and there can be no guarantee of future profits. Likewise, past performance is not necessarily indicative of future results. Stocks, futures, currencies, commodities, CFDs, options and all types of investment trading can have large potential rewards, but also carry large potential risks. We make absolutely no representation that gains or losses demonstrated in services published by Money Map Press LLC are likely or achievable. Please Note: Any performance results described herein are not based on actual trading of securities but are instead based on a hypothetical trading account which entered and exited the suggested positions in securities at the times and prices referenced. Hypothetical performance results have many inherent limitations. In fact, there are frequently sharp differences between hypothetical performance results and the actual results that may subsequently be achieved. One of the limitations of hypothetical performance results is that they are generally prepared with the benefit of hindsight. In addition, hypothetical trading does not involve financial risk, and no hypothetical trading record can completely account for the impact of financial risk in actual trading. For example, hypothetical trading examples cannot possibly take into account the impact of liquidity or buyer and seller demand, and do not allow for slippage and associated trading costs and concerns. One must be aware of the risks and be willing to accept them in order to invest in the markets. One should never trade with money that one cannot afford to lose, and one must accept that there will be losses, and one must be able to sustain these losses, both from a financial as well as an emotional perspective. Recommendations are for the exclusive use of subscribers and can change at any time. This work is based on SEC filings, current events, interviews, corporate press releases, and what we've learned as financial journalists. It may contain errors and you shouldn't make any investment decision based solely on what you read here. It's your money and your responsibility. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.
Protected by copyright laws of the United States and international treaties. This Newsletter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of Wall Street Insights & Indictments. 1125 N Charles Street, Baltimore MD 21201.
| |
没有评论:
发表评论